In 2003, an international working group last reported on recommendations for diagnosis,
response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that …

Competing risks endpoints are frequently encountered in hematopoietic stem cell
transplantation where patients are exposed to relapse and treatment-related mortality. Both …

Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation
(HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with …

Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation
(allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported …

Although transplant practices have changed over the last decades, no information is
available on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) …

Defining conditioning regimen intensity has become a critical issue for the hemopoietic stem
cell transplant (HSCT) community. In the present report we propose to define conditioning …

Allogeneic haematopoietic stem-cell transplantation (HSCT) is frequently applied as part of
the treatment in patients with acute myeloid leukaemia (AML) in their first or subsequent …

Total body irradiation (TBI) remains an effective myeloablative treatment in regimens used
for preparation and conditioning before allogeneic stem cell transplantation for leukemia …

Allogeneic hematopoietic stem cell transplantation (allo-SCT) remains the therapeutic
method with the most potent anti-leukemic activity mediated by the graft versus leukemia …

Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated
haploidentical bone marrow transplantation (BMT), followed by posttransplantation high …